Laurion Capital Management LP Nkarta, Inc. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$3.37 - $6.3 $758,250 - $1.42 Million
225,000 Added 23.15%
1,197,060 $4.25 Million
Q4 2022

Feb 14, 2023
BUY
$5.14 - $14.35 $516,688 - $1.44 Million
100,523 Added 11.53%
972,060 $5.82 Million
Q3 2022

Nov 14, 2022
BUY
$12.27 - $18.39 $67,656 - $101,402
5,514 Added 0.64%
871,537 $11.5 Million
Q2 2022

Aug 15, 2022
BUY
$7.77 - $19.44 $6.73 Million - $16.8 Million
866,023 New
866,023 $10.7 Million

Others Institutions Holding NKTX

# of Institutions
129
Shares Held
66.5M
Call Options Held
173K
Put Options Held
20K
View Full List

About Nkarta, Inc.

NKTX Quotes by TradingView
  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $127M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email